These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17087286)

  • 1. [Endothelial dysfunction and plaque inflammation in diabetic macroangiopathy].
    Ikura Y; Kitabayashi C; Ueda M
    Nihon Rinsho; 2006 Nov; 64(11):1980-3. PubMed ID: 17087286
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of diabetic macroangiopathy].
    Nishio Y
    Nihon Rinsho; 2006 Nov; 64(11):1991-7. PubMed ID: 17087288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches.
    Bauersachs J; Thum T
    Eur J Clin Invest; 2007 Aug; 37(8):603-6. PubMed ID: 17635570
    [No Abstract]   [Full Text] [Related]  

  • 5. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
    Yamagishi S
    Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy.
    Chiarelli F; Mansour M; Verrotti A
    Diabetes Nutr Metab; 2000 Aug; 13(4):192-9. PubMed ID: 10961486
    [No Abstract]   [Full Text] [Related]  

  • 7. [AGE-RAGE system in diabetic microangiopathy].
    Harashima A; Yamamoto Y; Yamamoto H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():62-6. PubMed ID: 15999686
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucose metabolism in vascular endothelial cells].
    Yokota C; Okuda Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():324-30. PubMed ID: 12238067
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes & coronary artery disease.
    Arvind K; Pradeepa R; Deepa R; Mohan V
    Indian J Med Res; 2002 Nov; 116():163-76. PubMed ID: 12710546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood cells and vascular cell interactions in diabetes.
    Wautier JL; Wautier MP
    Clin Hemorheol Microcirc; 2001; 25(2):49-53. PubMed ID: 11790870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial and coronary vessel dysfunction in diabetes I patients].
    Konduracka E; Galicka-Latała D; Piwowarska W; Sieradzki J
    Przegl Lek; 2002; 59(7):514-8. PubMed ID: 12516240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
    J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycation, receptor-mediated cell activation and vascular complications of diabetes.
    Thornalley PJ
    Diab Vasc Dis Res; 2004 May; 1(1):21-2. PubMed ID: 16305051
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial dysfunction, atherosclerosis and diabetes.
    Najemnik C; Sinzinger H; Kritz H
    Acta Med Austriaca; 1999; 26(5):148-53. PubMed ID: 11512191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
    Candido R; Zanetti M
    Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nitric oxide in the development of diabetic angiopathy.
    Santilli F; Cipollone F; Mezzetti A; Chiarelli F
    Horm Metab Res; 2004 May; 36(5):319-35. PubMed ID: 15156413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why does diabetes mellitus increase the risk of cardiovascular disease?
    Shahab A
    Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.